Scynexis Inc (SCYX) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Scynexis reported revenue of $20.6M, up 449.9% from $3.7M the year before. Net income was -$8.6M (a -41.8% net margin), or -$1.36 per diluted share. Operating margin was -78.0%. Operating activities generated -$5.3M of cash. At fiscal year end, Scynexis held $59.0M in total assets against $9.7M in total liabilities, including $21.3M of cash and equivalents.
Open the full interactive Scynexis financials → Quarterly statements, key ratios, valuation history and price charts.
Scynexis Key Stats
| Share Price | $3.99 |
|---|---|
| Market Cap | $47.2M |
| Revenue YoY Growth | +450.0% |
| 52-Week Range | $3.57 – $8.88 |
| Shares Outstanding | 11.8 million (basic, 2026 Q2) |
Scynexis Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $13.2M | $5.1M | $140.1M | $3.7M | $20.6M |
| Operating Income | -$51.1M | -$60.8M | -$85.8M | $72.7M | -$37.1M | -$16.1M |
| Pre-Tax Income | -$58.3M | -$36.0M | -$67.5M | $67.2M | -$21.1M | -$8.6M |
| Income Tax | -$3.1M | -$3.1M | -$4.7M | $138,000 | $151,000 | $0 |
| Net Income | -$55.2M | -$32.9M | -$62.8M | $67.0M | -$21.3M | -$8.6M |
| Diluted EPS | -$41.18 | -$9.97 | -$11.76 | $11.12 | -$3.52 | -$1.36 |
Scynexis Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $334,000 | $18.6M | $0 | $235,000 |
| Net Income | -$8.6M | $12.3M | -$21.3M | $7.4M |
| Diluted EPS | -$1.36 | $0.25 | -$3.36 | $0.63 |
Scynexis Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $93.0M | $104.5M | $45.8M | $34.0M | $16.1M | $21.3M |
| Current Assets | $98.2M | $109.4M | $79.1M | $102.1M | $72.2M | $40.4M |
| Total Assets | $102.5M | $119.8M | $87.8M | $128.4M | $90.6M | $59.0M |
| Current Liabilities | $26.4M | $13.6M | $17.6M | $16.3M | $24.1M | $5.7M |
| Total Long-Term Debt | — | $28.7M | $34.4M | — | — | — |
| Total Liabilities | $79.8M | $78.6M | $84.6M | $55.5M | $35.6M | $9.7M |
| Shareholders' Equity | $22.8M | $41.3M | $3.2M | $73.0M | $55.1M | $49.4M |
Scynexis Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$49.4M | -$54.6M | -$79.9M | $60.2M | -$24.0M | -$5.3M |
| Cash From Investing | $6.5M | -$1.2M | -$27.4M | -$34.9M | $6.2M | $24.3M |
| Cash From Financing | $94.0M | $67.1M | $48.6M | -$36.7M | -$139,000 | -$14.2M |
| Free Cash Flow | -$49.4M | -$54.6M | — | — | — | — |
Figures from Scynexis' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Scynexis financials page for every line item.
Scynexis Company Profile
| Ticker | SCYX |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Jersey City, New Jersey |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001178253 |
Frequently Asked Questions
What was Scynexis' revenue in fiscal 2025?
Scynexis (SCYX) reported revenue of $20.6M for fiscal 2025.
What is Scynexis' annual revenue history?
Scynexis' annual revenue by fiscal year: 2020: $0; 2021: $13.2M; 2022: $5.1M; 2023: $140.1M; 2024: $3.7M; 2025: $20.6M.
What was Scynexis' net income in fiscal 2025?
Scynexis reported net income of -$8.6M for fiscal 2025.
What was Scynexis' earnings per share (EPS) in fiscal 2025?
Scynexis' diluted EPS was -$1.36 for fiscal 2025 (adjusted for any later stock splits).
What was Scynexis' revenue last quarter?
In its most recent reported quarter (2026 Q2), Scynexis reported revenue of $235,000.
How many shares of Scynexis are outstanding?
Scynexis reported a weighted average of 11.8 million basic shares outstanding in 2026 Q2.
What is Scynexis' market cap?
Based on its latest closing price, Scynexis (SCYX) has a market capitalization of about $47.2M.
When does Scynexis' fiscal year end?
Scynexis' fiscal year end, as registered with the SEC, is December 31.
Where is Scynexis headquartered?
Scynexis lists its business address in Jersey City, New Jersey in its SEC filings.